Peter A Revill

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Topics

Hepatitis B Virus

Magnetic Resonance

Top Venues

Journal of virology

Alimentary pharmacology & therapeutics

Nature reviews. Gastroenterology & hepatology

This page only lists publications with an associated author ORCID identifier.

Publications

Laura C McCoullough, Tomas Sadauskas, Vitina Sozzi, Kai Yan Mak, Hugh Mason, Margaret Littlejohn, Peter A Revill
The in vitro replication phenotype of hepatitis B virus (HBV) splice variants Sp3 and Sp9 and their impact on wild-type HBV replication. Journal of virology 98 (4) (2024)
Laura C McCoullough, Tomas Sadauskas, Vitina Sozzi, Kai Yan Mak, Hugh Mason, Margaret Littlejohn, Peter A Revill
The in vitro replication phenotype of hepatitis B virus (HBV) splice variants Sp3 and Sp9 and their impact on wild-type HBV replication. Journal of virology (2024)
Laura C McCoullough, Tomas Sadauskas, Vitina Sozzi, Kai Yan Mak, Hugh Mason, Margaret Littlejohn, Peter A Revill
The in vitro replication phenotype of hepatitis B virus (HBV) splice variants Sp3 and Sp9 and their impact on wild-type HBV replication. Journal of virology 98 (4) (2024)
Laura C McCoullough, Tomas Sadauskas, Vitina Sozzi, Kai Yan Mak, Hugh Mason, Margaret Littlejohn, Peter A Revill
The in vitro replication phenotype of hepatitis B virus (HBV) splice variants Sp3 and Sp9 and their impact on wild-type HBV replication. Journal of virology 98 (4) (2024)
Laura C McCoullough, Tomas Sadauskas, Vitina Sozzi, Kai Yan Mak, Hugh Mason, Margaret Littlejohn, Peter A Revill
The in vitro replication phenotype of hepatitis B virus (HBV) splice variants Sp3 and Sp9 and their impact on wild-type HBV replication. Journal of virology 98 (4) (2024)
Josef Wagner, Margaret Littlejohn, Peter A Revill
Editorial: baseline hepatitis B virus haplotype number may help predict a functional cure in patients with chronic hepatitis B treated with nucleotide analogues-authors' reply. Alimentary pharmacology & therapeutics 57 (5) (2023)
Anna Kramvis, Kyong-Mi Chang, Maura Dandri, Patrizia Farci, Dieter Glebe, Jianming Hu, Harry L A Janssen, Daryl T Y Lau, Capucine Penicaud, Teresa Pollicino, Barbara Testoni, Florian Van Bömmel, Ourania Andrisani, Maria Beumont-Mauviel, Timothy M Block, Henry L Y Chan, Gavin A Cloherty, William E Delaney, Anna Maria Geretti, Adam J Gehring, Kathy Jackson, Oliver Lenz, Mala K Maini, Veronica Miller, Ulrike Protzer, Jenny C Yang, Man-Fung Yuen, Fabien Zoulim, Peter A Revill
A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook. Nature reviews. Gastroenterology & hepatology 19 (11) (2022)
Josef Wagner, Lilly Yuen, Margaret Littlejohn, Vitina Sozzi, Kathy Jackson, Ross Martin, Thomas Aeschbacher, Vithika Suri, Susanna K Tan, Becket Feierbach, Anuj Gaggar, Patrick Marcellin, Maria Buti Ferret, Harry L A Janssen, Ed Gane, Niamh Meagher, David J Price, Darren Wong, Alexander T Thompson, Peter A Revill
Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D HBeAg-positive chronic hepatitis B. Alimentary pharmacology & therapeutics (2022)
Jack Wallace, Jacqueline Richmond, Jessica Howell, Behzad Hajarizadeh, Jennifer Power, Carla Treloar, Peter A Revill, Benjamin Cowie, Su Wang, Mark Stoové, Alisa Pedrana, Margaret Hellard
Exploring the Public Health and Social Implications of Future Curative Hepatitis B Interventions. Viruses 14 (11) (2022)
Olivia Maslac, Josef Wagner, Vitina Sozzi, Hugh Mason, Jenny Svarovskaia, Susanna Tan, Anuj Gaggar, Stephen Locarnini, Lilly Yuen, Margaret Littlejohn, Peter A Revill
Secreted hepatitis B virus splice variants differ by HBV genotype and across phases of chronic hepatitis B infection. Journal of viral hepatitis 29 (8) (2022)